Meredith
Meredith Bell, Marshalltown, IA US
Patent application number | Description | Published |
---|---|---|
20150088434 | VALVE PROGNOSTICS FOR POLYMERIC COMPONENTS BASED ON ACCELERATED AGING TECHNIQUES - The claimed method and system develops accelerated aging test protocols for a component of a process control device, such as a polymeric component of a valve assembly, where the accelerated aging test protocol is specifically developed in response to expected operating conditions to be used during operation of the process control device in a process plant installation. Test data from the developed accelerated aging tests is analyzed to determine a projected lifetime profile of the component that profiles the component through failure under those expected operating conditions. Particular profiling for polymeric features includes oxidation failure profiling and other fatigue conditions. | 03-26-2015 |
Meredith Flynn-Ripley, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20100037277 | Apparatus and Methods for TV Social Applications - A system for implementing a content-centered chat room operates to display messages received from one or more invitees of a subscriber on the subscriber's TV as program content is displayed on the subscriber's TV. The subscriber and the invitees all watch television, either a common TV program or different TV programs. Participants may be located in the same or in several different locations, and if the invitee-participants are also subscribers, the chat room may also appear on their TV screens. A subscriber invites friends to participate in the chat session for a specific TV program using the set top box (STB) of his television to send invitations, and a dedicated subscriber server coordinates notification of the invitees and directs their message-comments to a chat session displayed with the program content. In one embodiment, participants or the participants who are not also subscribers of the TVChat service or whose televisions are otherwise not chat-enabled, may receive other participants' chat messages by mobile phone. | 02-11-2010 |
Meredith Hall, Newbliss IE
Patent application number | Description | Published |
---|---|---|
20090145697 | FORKLIFT TRUCKS - A forklift truck ( | 06-11-2009 |
Meredith Hans Moore, West Chester, PA US
Patent application number | Description | Published |
---|---|---|
20120219599 | OSTEOGENIC PROMOTING IMPLANTS AND METHODS OF INDUCING BONE GROWTH - The present disclosure describes an implant for improving bone growth including an osteoconductive scaffold and an osteoinductive small molecule. The osteoconductive scaffold can further include a polymeric binder. The implant can also include an osteogenic material to provide a viable cell population to assist the bone repair and remodeling. Also disclosed is a system for forming an implant for improving bone growth, as well as methods for forming the implant according to the disclosure, in addition to methods of therapeutic use of the implant. | 08-30-2012 |
20140274649 | Bone Marrow Concentrator - Instrumentation is provided for the separation of a multiple component sample, such as BMA containing lysed red blood cells and a lysing agent, into a desired component, for example a cell pellet containing stem cells, and a remaining component. The application discloses a device that includes a separator configured to separate the desired portion from the remaining portion, a collector that is supported by the separator and configured to collect the desired component of the multiple component sample after the desired component has been separated from the remaining component by the separator, and a housing that at least partially encloses and supports the separator and the collector. | 09-18-2014 |
Meredith Jones, Chapel Hill, NC US
Patent application number | Description | Published |
---|---|---|
20130316400 | HIGH YIELD TRANSIENT EXPRESSION IN MAMMALIAN CELLS USING UNIQUE PAIRING OF HIGH DENSITY GROWTH AND TRANSFECTION MEDIUM AND EXPRESSION ENHANCERS - The present invention is directed generally to cell culture media (particularly serum free, non animal derived, and/or chemically defined media) which are useful for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). According to the invention, such introduction can take place in the presence of said medium. Cells containing such introduced materials can then be cultured in the medium and the effect of the introduced materials on the cells can be measured or determined. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly eukaryotic cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells. | 11-28-2013 |
Meredith Maycotte, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20140075018 | Systems and Methods of Audience Measurement - A particular method includes receiving, at a computing device including a processor, a first event signal that includes a first browser identifier and first information indicative of a first interaction with respect to a media property. The method also includes determining that the first browser identifier corresponds to a particular user and associating the first event signal with a user profile of the particular user. The method further includes receiving a second event signal that includes a second browser identifier that is different from the first browser identifier and second information indicative of a second interaction with respect to the media property. The method includes determining that the second browser identifier corresponds to the particular user and associating the second event signal with the user profile. | 03-13-2014 |
Meredith Mchugh Karow, Hatboro, PA US
Patent application number | Description | Published |
---|---|---|
20100147708 | SUTURE TRAY PACKAGE - A novel suture tray package is disclosed. The package has a floor member and a plurality of curvilinear walls extending up from the top of the floor member and forming suture tracks. The walls extend in a spiral manner from the central section of the floor member to the periphery. Extending radially outwardly about the periphery are platform sections in communication with the tracks and optionally containing needle park members and pledget park members. | 06-17-2010 |
20110215005 | SUTURE PACKAGES PROVIDING UNCONSTRAINED DISPENSING OF SUTURES AND METHODS THEREFOR - A suture package includes a first part or base having an outer surface, an inner surface, and a plurality of openings extending between the outer and inner surfaces, and a second part or lid having an outer surface, an inner surface, and a plurality of posts projecting from the inner surface. The suture package has a closed configuration in which the inner surface of the lid opposes the inner surface of the base with distal ends of the posts engaging the inner surface of the base at locations that are offset from and adjacent the plurality of openings extending through the base. The package includes a hinge interconnecting the lid and the base for opening and closing the suture package. Suture winding posts on a fixture are passable through the base openings for winding at least one suture around the suture winding posts for positioning the at least one suture on the base. | 09-08-2011 |
Meredith Perry, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20150326034 | POWER DENSITY CONTROL FOR WIRELESS POWER TRANSFER - A signal generator generates an electrical signal that is sent to an amplifier, which increases the power of the signal using power from a power source. The amplified signal is fed to a sender transducer to generate ultrasonic waves that can be focused and sent to a receiver. The receiver transducer converts the ultrasonic waves back into electrical energy and stores it in an energy storage device, such as a battery, or uses the electrical energy to power a device. In this way, a device can be remotely charged or powered without having to be tethered to an electrical outlet. | 11-12-2015 |
20150333798 | OSCILLATOR CIRCUITS FOR WIRELESS POWER TRANSFER - A signal generator generates an electrical signal that is sent to an amplifier, which increases the power of the signal using power from a power source. The amplified signal is fed to a sender transducer to generate ultrasonic waves that can be focused and sent to a receiver. The receiver transducer converts the ultrasonic waves back into electrical energy and stores it in an energy storage device, such as a battery, or uses the electrical energy to power a device. In this way, a device can be remotely charged or powered without having to be tethered to an electrical outlet. | 11-19-2015 |
20150333799 | BEAM INTERACTION CONTROL FOR WIRELESS POWER TRANSFER - A signal generator generates an electrical signal that is sent to an amplifier, which increases the power of the signal using power from a power source. The amplified signal is fed to a sender transducer to generate ultrasonic waves that can be focused and sent to a receiver. The receiver transducer converts the ultrasonic waves back into electrical energy and stores it in an energy storage device, such as a battery, or uses the electrical energy to power a device. In this way, a device can be remotely charged or powered without having to be tethered to an electrical outlet. | 11-19-2015 |
20150333800 | MOTION PREDICTION FOR WIRELESS POWER TRANSFER - A signal generator generates an electrical signal that is sent to an amplifier, which increases the power of the signal using power from a power source. The amplified signal is fed to a sender transducer to generate ultrasonic waves that can be focused and sent to a receiver. The receiver transducer converts the ultrasonic waves back into electrical energy and stores it in an energy storage device, such as a battery, or uses the electrical energy to power a device. In this way, a device can be remotely charged or powered without having to be tethered to an electrical outlet. | 11-19-2015 |
Meredith Pohland, Memphis, TN US
Patent application number | Description | Published |
---|---|---|
20150157509 | OCCLUSIVE SKIN COVERING - A device for concealing an area of skin is disclosed. The disclosed device can also be used to deliver to the concealed skin area one or more beneficial agents. The device is designed as a laminate having a removable release liner, an occlusive layer, and a finish layer. In some delivery platform embodiments, the occlusive layer includes a reservoir for holding and releasing the one or more beneficial agents to the user's skin. The device is applied to the skin by removing the release liner and placing the exposed adhesive layer of the occlusive device directly on the user's skin. | 06-11-2015 |
Meredith Savignano, Hull, MA US
Patent application number | Description | Published |
---|---|---|
20160037944 | WEIGHTED BLANKET SYSTEM - A weighted blanket system that improves the beach experience is described. The weighted blanket system is convenient to use, and store and carry. In addition, the weighted blanket system requires very little time to set up. The weighted blanket system can include a sheet; at least one beanbag; at least one pillow; at least one pocket permanently fastened to the sheet, and at least one pocket securable to the sheet. The sheet can include one or more holes. | 02-11-2016 |
Meredith Shaebanyan, Anaheim, CA US
Patent application number | Description | Published |
---|---|---|
20100169642 | Remote virtual medical diagnostic imaging viewer - A medical image and data application service provider system provides a way of remotely viewing and manipulating medical images and data for diagnostic and visualization purposes by users unconstrained by geography. Medical images and data are stored on one or more servers running application service provider software along with meta-data such as access control information, origin of information and references to related data. A set of medical data consisting related information is sent as an encrypted stream to a viewing station running client software in a secure execution environment that is logically independent of the viewing station's operating system. | 07-01-2010 |
20120224754 | REMOTE DATA VIEWER - A medical image and data application service provider system provides a way of remotely viewing and manipulating medical images and data for diagnostic and visualization purposes by users unconstrained by geography. Medical images and data are stored on one or more servers running application service provider software along with meta-data such as access control information, origin of information and references to related data. A set of medical data consisting related information is sent as an encrypted stream to a viewing station running client software in a secure execution environment that is logically independent of the viewing station's operating system. | 09-06-2012 |
20120227113 | REMOTE DATA VIEWER - A medical image and data application service provider system provides a way of remotely viewing and manipulating medical images and data for diagnostic and visualization purposes by users unconstrained by geography. Medical images and data are stored on one or more servers running application service provider software along with meta-data such as access control information, origin of information and references to related data. A set of medical data consisting related information is sent as an encrypted stream to a viewing station running client software in a secure execution environment that is logically independent of the viewing station's operating system. | 09-06-2012 |
Meredith Smith, Lake Forest, IL US
Patent application number | Description | Published |
---|---|---|
20090083334 | SYSTEM AND METHODS FOR MANAGEMENT OF RISK DATA AND ANALYTICS - Managing and analyzing occurrences of certain types of adverse events associated with a distribution of a prescription drug into the commercial marketplace, such as a drug having an associated abuse liability potential. Data concerning an occurrence of an adverse event associated with such distribution is received and selectively logged as an event if the data satisfies one or more predetermined criteria which can be used to filter the received data. If the received data are logged as an event, a score is computed and assigned to the event. If the score meets or exceeds a pre-established threshold, a field researcher is assigned to investigate the logged event. Further data from the field researcher are stored in association with the logged event. Automated review of further data from field researchers can be performed to update the status of a logged event to closed. | 03-26-2009 |
Meredith Williams, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20110082107 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 - The present invention relates to compounds with the formula (I), (II), (III) or (IV): | 04-07-2011 |
20120010256 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 - The present invention relates to compounds with the formula (I), (II), (III) or (IV): | 01-12-2012 |
Meredith Williams, Singapore SG
Patent application number | Description | Published |
---|---|---|
20100298319 | PYRIMIDINE SUBSTITUTED PURINE DERIVATIVES - The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with PI3 and/or mTOR kinases. | 11-25-2010 |
20110009403 | 2-MORPHOLINYLPURINES AS INHIBITORS OF PI3K - The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other disorders or conditions related to or associated with mTOR kinases. | 01-13-2011 |
20110105500 | PYRAZINE SUBSTITUTED PURINES - The present invention relates to purine compounds of formula (I) that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with PI3K and/or mTOR kinases. | 05-05-2011 |
20120142683 | PYRIMIDINE SUBSTITUTED PURINE COMPOUNDS AS KINASE (S) INHIBITORS - The present invention relates to a purine compound useful as a kinase inhibitor. The compound has the structure (I) or a pharmaceutically acceptable salt thereof | 06-07-2012 |
20130079512 | PYRIMIDINE SUBSTITUTED PURINE DERIVATIVES - The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with PI3 and/or mTOR kinases. | 03-28-2013 |
20140066620 | PYRIMIDINE SUBSTITUTED PURINE DERIVATIVES - The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with PI3 and/or mTOR kinases. | 03-06-2014 |
20150105382 | PYRIMIDINE SUBSTITUTED PURINE COMPOUNDS AS KINASE (S) INHIBITORS - The present invention relates to a purine compound useful as a kinase inhibitor. The compound has the structure: | 04-16-2015 |